Lactulose/mannitol test and specificity, sensitivity, and area under curve of intestinal permeability parameters in patients with liver cirrhosis and Crohn's disease
- PMID: 18320320
- DOI: 10.1007/s10620-007-0184-8
Lactulose/mannitol test and specificity, sensitivity, and area under curve of intestinal permeability parameters in patients with liver cirrhosis and Crohn's disease
Abstract
The purpose of this study was to investigate and compare the specificity, sensitivity, and area under curve (AUC) of the lactulose/mannitol ratio, lactulose/creatinine ratio, and lactulose recovery and their diagnostic value for intestinal permeability assessment within the absorption lactulose/mannitol (L/M) test.
Results: The value of the lactulose/mannitol ratio, lactulose/creatinine ratio, and the percentage of lactulose recovery in Crohn's disease (0.0763 +/- 0.0369; 99.62 +/- 67.87; 1.0478 +/- 0.6148) and in liver cirrhosis (0.0517 +/- 0.0365; 54.65 +/- 53.26; 0.838 +/- 0.929) were significantly different from the values measured in the control group (0.0123 +/- 0.0081; 10.95 +/- 7.07; 0.2438 +/- 0.1568), P < 0.0001-0.002). In Crohn's disease, specificity, sensitivity, and AUC were 100%, 89.5%, and 0.987, respectively, of the lactulose/mannitol ratio at a cut-off level of 0.022. In liver cirrhosis, the test characteristics were 88.5%, 84.2%, and 0.910 at a cut-off level of 0.018.
Conclusion: The lactulose/mannitol ratio was evaluated to have the highest diagnostic value to assess intestinal permeability.
Similar articles
-
Gut permeability to lactulose and mannitol differs in treated Crohn's disease and celiac disease patients and healthy subjects.Braz J Med Biol Res. 2008 Dec;41(12):1105-9. doi: 10.1590/s0100-879x2008001200010. Braz J Med Biol Res. 2008. PMID: 19148373
-
Increased intestinal permeability and NOD2 variants in familial and sporadic Crohn's disease.Aliment Pharmacol Ther. 2006 May 15;23(10):1455-61. doi: 10.1111/j.1365-2036.2006.02916.x. Aliment Pharmacol Ther. 2006. PMID: 16669960
-
Patients with ankylosing spondylitis and healthy relatives do not show increased small intestinal permeability with the lactulose-mannitol test.Clin Exp Rheumatol. 1993 Jul-Aug;11(4):413-6. Clin Exp Rheumatol. 1993. PMID: 8403588
-
Assessment of hypolactasia and site-specific intestinal permeability by differential sugar absorption of raffinose, lactose, sucrose and mannitol.Clin Chem Lab Med. 2003 Aug;41(8):1056-63. doi: 10.1515/CCLM.2003.163. Clin Chem Lab Med. 2003. PMID: 12964814
-
Bei Leberzirrhose immer Lactulose geben?MMW Fortschr Med. 2024 Feb;166(3):26. doi: 10.1007/s15006-024-3651-7. MMW Fortschr Med. 2024. PMID: 38389000 Review. German. No abstract available.
Cited by
-
Surrogate Markers of Intestinal Permeability, Bacterial Translocation and Gut-Vascular Barrier Damage Across Stages of Cirrhosis.Liver Int. 2025 Jun;45(6):e70119. doi: 10.1111/liv.70119. Liver Int. 2025. PMID: 40317887 Free PMC article.
-
A Rapid and Reliable Spectrofluorimetric Method to Measure the Urinary Lactulose/Mannitol Ratio for Dysbiosis Assessment.Biomedicines. 2024 Jul 13;12(7):1557. doi: 10.3390/biomedicines12071557. Biomedicines. 2024. PMID: 39062130 Free PMC article.
-
Leaky Gut and Gut-Liver Axis in Liver Cirrhosis: Clinical Studies Update.Gut Liver. 2021 Sep 15;15(5):666-676. doi: 10.5009/gnl20032. Gut Liver. 2021. PMID: 33071239 Free PMC article. Review.
-
Intestinal permeability in subjects from two different race groups with diverse stone-risk profiles.Urolithiasis. 2013 Apr;41(2):111-7. doi: 10.1007/s00240-013-0543-1. Epub 2013 Jan 22. Urolithiasis. 2013. PMID: 23503872
-
Abnormal small intestinal permeability in patients with idiopathic malabsorption in tropics (tropical sprue) does not change even after successful treatment.Dig Dis Sci. 2011 Jan;56(1):161-9. doi: 10.1007/s10620-010-1232-3. Epub 2010 Apr 22. Dig Dis Sci. 2011. PMID: 20411417
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical